HC Wainwright Reiterates Buy Rating on Rigel Pharmaceuticals, Keeps $85 Target
HC Wainwright reiterated its Buy rating and $85.00 price target. The target implies 84.9% upside from the Oct. 16 close of $45.97.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.